Hilde Vroling

908 total citations · 1 hit paper
17 papers, 520 citations indexed

About

Hilde Vroling is a scholar working on Epidemiology, Infectious Diseases and Dermatology. According to data from OpenAlex, Hilde Vroling has authored 17 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 7 papers in Infectious Diseases and 5 papers in Dermatology. Recurrent topics in Hilde Vroling's work include Herpesvirus Infections and Treatments (6 papers), Respiratory viral infections research (5 papers) and Acne and Rosacea Treatments and Effects (5 papers). Hilde Vroling is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Respiratory viral infections research (5 papers) and Acne and Rosacea Treatments and Effects (5 papers). Hilde Vroling collaborates with scholars based in United States, Belgium and United Kingdom. Hilde Vroling's co-authors include Desmond Curran, Barbara P. Yawn, Desirée Van Oorschot, Eveline M. Bunge, John Diaz‐Decaro, Anouk Oordt-Speets, Caroline van den Ende, Heleen M.E. van Agt, Elizabeth Begier and Daniel Curcio and has published in prestigious journals such as The Journal of Infectious Diseases, International Journal of Cancer and European Respiratory Journal.

In The Last Decade

Hilde Vroling

16 papers receiving 508 citations

Hit Papers

Underascertainment of Respiratory Syncytial Virus Infecti... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilde Vroling United States 12 397 115 71 65 61 17 520
Nirma Khatri Vadlamudi Canada 10 306 0.8× 36 0.3× 51 0.7× 33 0.5× 69 1.1× 27 419
Abeer Moanna United States 11 208 0.5× 309 2.7× 43 0.6× 21 0.3× 59 1.0× 20 536
Freddy Caldera United States 15 262 0.7× 268 2.3× 47 0.7× 16 0.2× 22 0.4× 89 617
José Ángel Rodrigo‐Pendás Spain 12 472 1.2× 75 0.7× 5 0.1× 60 0.9× 72 1.2× 33 579
Schmid Switzerland 6 403 1.0× 79 0.7× 74 1.0× 24 0.4× 23 0.4× 16 794
Kurt Banz Germany 13 266 0.7× 32 0.3× 65 0.9× 55 0.8× 4 0.1× 30 431
Robert Samuel United Kingdom 8 330 0.8× 95 0.8× 10 0.1× 28 0.4× 8 0.1× 15 467
Wasna Sirirungsi Thailand 15 270 0.7× 240 2.1× 40 0.6× 19 0.3× 7 0.1× 42 523
V. Delcey France 14 385 1.0× 302 2.6× 27 0.4× 20 0.3× 19 0.3× 29 770

Countries citing papers authored by Hilde Vroling

Since Specialization
Citations

This map shows the geographic impact of Hilde Vroling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Vroling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Vroling more than expected).

Fields of papers citing papers by Hilde Vroling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Vroling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Vroling. The network helps show where Hilde Vroling may publish in the future.

Co-authorship network of co-authors of Hilde Vroling

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Vroling. A scholar is included among the top collaborators of Hilde Vroling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Vroling. Hilde Vroling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Meulen, Ajoke Sobanjo-ter, et al.. (2025). The Burden of Human Metapneumovirus (hMPV) Disease in Older and High-Risk Adults in Developed Countries: A Systematic Literature Review. Infectious Diseases and Therapy. 14(8). 1917–1933. 1 indexed citations
2.
Curcio, Daniel, Zuleika Aponte‐Torres, Marc Baay, et al.. (2024). Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious Diseases and Therapy. 13(8). 1725–1742. 22 indexed citations
3.
Mortimer, Kevin, et al.. (2024). Global herpes zoster burden in adults with asthma: a systematic review and meta-analysis. European Respiratory Journal. 64(2). 2400462–2400462. 1 indexed citations
4.
Gessner, Bradford D., Sonia Menon, Hilde Vroling, et al.. (2024). Respiratory Syncytial Virus Sequelae Among Adults in High-Income Countries: A Systematic Literature Review and Meta-analysis. Infectious Diseases and Therapy. 13(7). 1399–1417. 9 indexed citations
5.
Curran, Desmond, et al.. (2024). The Incidence of Herpes Zoster Complications: A Systematic Literature Review. Infectious Diseases and Therapy. 13(7). 1461–1486. 14 indexed citations
6.
Bhavsar, Amit, et al.. (2024). Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK. Infectious Diseases and Therapy. 13(5). 1083–1104. 5 indexed citations
7.
Onwuchekwa, Chukwuemeka, Sonia Menon, Daniel Curcio, et al.. (2023). Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis. The Journal of Infectious Diseases. 228(2). 173–184. 99 indexed citations breakdown →
8.
Onwuchekwa, Chukwuemeka, Jessica E. Atwell, Sonia Menon, et al.. (2023). Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis. The Journal of Infectious Diseases. 228(11). 1516–1527. 22 indexed citations
9.
Curran, Desmond, Andrea Callegaro, Kyle Fahrbach, et al.. (2021). Meta-Regression of Herpes Zoster Incidence Worldwide. Infectious Diseases and Therapy. 11(1). 389–403. 45 indexed citations
10.
Oorschot, Desirée Van, Hilde Vroling, Eveline M. Bunge, et al.. (2021). A systematic literature review of herpes zoster incidence worldwide. Human Vaccines & Immunotherapeutics. 17(6). 1714–1732. 122 indexed citations
11.
Oorschot, Desirée Van, Hilde Vroling, Eveline M. Bunge, et al.. (2019). PIN106 SYSTEMATIC LITERATURE REVIEW OF HERPES ZOSTER INCIDENCE WORLDWIDE. Value in Health. 22. S656–S656.
12.
Madeddu, Giordano, Hilde Vroling, Anouk Oordt-Speets, et al.. (2019). Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries. Vaccine. 37(35). 4906–4919. 21 indexed citations
13.
Tavoschi, Lara, Hilde Vroling, Giordano Madeddu, et al.. (2018). Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area. Epidemiologic Reviews. 40(1). 105–120. 32 indexed citations
14.
Vroling, Hilde, Anouk Oordt-Speets, Giordano Madeddu, et al.. (2018). A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA. Journal of Viral Hepatitis. 25(12). 1406–1422. 27 indexed citations
15.
Ende, Caroline van den, Anouk Oordt-Speets, Hilde Vroling, & Heleen M.E. van Agt. (2017). Benefits and harms of breast cancer screening with mammography in women aged 40–49 years: A systematic review. International Journal of Cancer. 141(7). 1295–1306. 52 indexed citations
16.
Willame, Corinne, Dominique Rosillon, Anke L. Stuurman, et al.. (2016). Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Human Vaccines & Immunotherapeutics. 12(11). 2862–2871. 37 indexed citations
17.
Varghese, Lijoy, Desmond Curran, Eveline M. Bunge, et al.. (2016). Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK. Public Health. 142. 46–49. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026